精神治療薬ハンドブック<br>Handbook of Psychiatric Drugs

個数:

精神治療薬ハンドブック
Handbook of Psychiatric Drugs

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 264 p.
  • 言語 ENG
  • 商品コード 9780470028216
  • DDC分類 615.788

基本説明

Each chapter is organised by drug class and follows a standard format for ease of use. Concise sections on phamacology and indications for use are followed by detailed information on drug selection, initiation and maintenance of treatment and withdrawal.

Full Description

The Handbook of Psychiatric Drugs is a comprehensive, clear, concise and quick reference to psychiatric drug therapies, designed to guide the clinician on the selection and implementation of treatment for mental illness. Each chapter is organised by drug class and follows a standard format for ease of use. Concise sections on pharmacology and indications for use are followed by detailed information on drug selection, initiation and maintenance of treatment and withdrawal. Adverse effects, contraindications and drug interactions are also reviewed in detail, along with issues such as treatment resistance and treatment evaluation.

A handy pocket-sized drug reference, the Handbook of Psychiatric Drugs makes it easy to keep up-to-date with new developments. It is an invaluable resource for all clinicians who use psychiatric drugs to treat medical and psychiatric illness, and an informative read for all those with an interest in the subject.

Contents

Preface. Acknowledgements.

Disclaimer.

1 Antipsychotic Drugs.

Introduction.

Pharmacology.

Chemistry.

Mechanism of Action.

Pharmacokinetics.

Indications for Use of Antipsychotic Drugs.

Drug Selection and Initiation of Treatment.

Drug Selection for the Treatment of Schizophrenia.

Effects of Antipsychotic Agents on Symptoms of Schizophrenia.

Drug Selection for the Treatment of Bipolar Disorder.

Drug Selection for the Treatment of Major Depression With Psychotic Features.

Drug Selection for the Treatment of Delusional Disorder.

Drug Selection for the Treatment of Delirium.

Drug Selection for the Treatment of Psychosis and Agitation Associated with Dementia.

Drug Selection for the Treatment of Mental Retardation and Developmental Disorders.

Drug Selection for Huntington's Disease and Tourette's Disorder.

Substance-induced Psychoses.

Adverse Effects of Antipsychotics.

Acute Extrapyramidal Side Effects (Dystonia, Parkinsonism, Akathisia).

Tardive Dyskinesia and Other Tardive Syndromes.

Neuroleptic Malignant Syndrome.

Endocrine and Sexual Effects.

Metabolic Effects.

Cardiovascular Effects.

Gastrointestinal Effects.

Hepatic Effects.

Hematological Effects.

Other Side Effects.

Drug Interactions and Antipsychotic Agents.

Antipsychotic Medications and Pregnancy.

Additional Reading.

2 Antidepressants.

Introduction.

Pharmacology.

Mechanisms of Action.

Pharmacokinetics.

Indications for Use of Antidepressants.

Panic Disorder (PD).

Obsessive-Compulsive Disorder (OCD).

Generalized Anxiety Disorder (GAD).

Social Phobias and Posttraumatic Stress Disorder (PTSD).

Bulimia.

Anorexia Nervosa.

Body Dysmorphic Disorder (BDD).

Premenstrual Dysphoria (PMDD).

Childhood Disorders.

Other Psychiatric Disorders.

Other Medical Conditions.

Drug Selection and Initiation of Treatment for Major Depression.

Special Considerations in the Selection of an Antidepressant.

Initiation of Treatment.

Therapeutic Drug Monitoring.

Early, or Pre-response, Period.

Response, or Acute Treatment, Period.

Treatment of Partially Responsive and Nonresponsive Patients.

Antidepressant Augmentation.

Changing to a New Agent.

Continuation and Maintenance Periods, and Discontinuation.

Side Effects.

Anticholinergic Effects.

Autonomic Effects.

Neurologic Effects.

Weight Gain.

Gastrointestinal Symptoms.

Sexual Dysfunction.

Cardiac Conduction.

Suicide Risk.

Allergic and Hematologic Effects.

Other Effects.

Central Serotonergic Syndrome.

Monoamine Oxidase Inhibitors.

Drug Interactions.

Tricyclic Antidepressants.

Pharmacokinetic Effects.

Monoamine Oxidase Inhibitors.

Serotonin Reuptake Inhibitors.

Other Second-Generation Antidepressants.

Third-Generation Antidepressants.

Summary.

Recommendations for the Use of Antidepressants.

Additional Reading.

3 Mood Stabilizers.

Introduction.

Pharmacology.

Chemistry.

Mechanism of Action.

Pharmacokinetics.

Indications.

Drug Selection and Initiation of Treatment.

Acute Mania.

Drug Selection.

Relative Efficacy of Different Agents.

Treatment Initiation and Dose Titration.

Acute Depression.

Drug Selection.

Treatment Initiation and Dose Titration.

Breakthrough Episodes.

Maintenance.

Rapid Cycling.

Costs.

Adverse Effects.

Drug Interactions.

Pregnancy.

Summary.

Additional Reading.

4 Anxiolytic Drugs.

Introduction.

A General Approach to Using Medication with Anxious Patients.

Pharmacology.

Antidepressants.

Benzodiazepines.

Buspirone.

Beta-Blocker Medications.

Anticonvulsants.

Antipsychotics.

Indications for Use.

Antidepressants.

Benzodiazepines.

Buspirone.

Beta-blocker Medications.

Anticonvulsants.

Antipsychotics.

Augmentation/Adjuvant Treatments.

Drug Selection, Dose, and Initiation of Treatment.

Side Effects.

Drug Interactions.

Contraindications and Special Precautions.

Summary.

Additional Reading.

5 Sedative-Hypnotic Agents.

Introduction.

Diagnosis.

Treatment Options.

Non-prescription Agents.

Prescription Medications.

Pharmacology.

Benzodiazepines.

Chloral Hydrate.

Zolpidem.

Zaleplon.

Eszopiclone.

Ramelteon.

Drug Selection.

Other Prescription Hypnotics.

Treatment Implementation.

Adverse Effects.

Benzodiazepines.

Chloral Hydrate.

Zolpidem.

Zaleplon.

Eszopiclone.

Ramelteon.

Drug Interactions and Special Precautions.

Summary.

Additional Reading.

6 Psychostimulants.

Introduction.

Pharmacology.

Chemistry.

Mechanism of Action.

Pharmacokinetics.

Indications and Contraindications.

Drug Selection.

Treatment Initiation and Dose Titration.

Treatment Evaluation.

Maintenance Treatment.

Treatment Resistance.

Effects of Treatment on Symptoms.

ADHD in Adults.

Alternative Preparations to the Standard Stimulant Medications.

Narcolepsy.

Other Indications.

Costs.

Adverse Effects.

Drug Interactions.

Summary.

Additional Reading.

7 Cognitive Enhancers and Treatments for Alzheimer's Disease.

Introduction.

Pharmacology.

Mechanism of Action.

Pharmacokinetics.

Indications.

Drug Selection.

Treatment Initiation.

Maintenance Treatment.

Treatment Evaluation.

Adverse Effects.

Cholinesterase Inhibitors.

Drug Interactions.

Summary.

Additional Reading.

8 Drugs for Treating Substance Abuse Disorders.

Introduction.

Syndromes Associated with Intoxication.

Alcohol Intoxication.

Sedative-Hypnotic Intoxication.

Opiate Intoxication.

Cocaine and Amphetamine Intoxication.

Intoxication by LSD, Mescaline, MDMA ('Ecstasy'), and Psilocybin.

Phencyclidine Intoxication.

Drug Treatment of Withdrawal Syndromes.

Alcohol Withdrawal.

Withdrawal from Sedative-Hypnotics.

Withdrawal from Opiates.

Management of Withdrawal in Patients with Multiple Dependencies.

Agents to Aid Relapse Prevention.

Medications for Alcohol Dependence.

Medications for Cocaine Dependence.

Medications for Opiate Dependence.

Special Considerations.

Drug Treatments for Nicotine Dependence.

Pharmacotherapies for Substance Abusers with Additional Psychiatric Illness.

Pharmacotherapy for Specific Psychiatric Disorders.

Drug Interactions in Chemical Dependency.

Additional Reading.

Index.

最近チェックした商品